Details for Patent: 8,474,447

✉ Email this page to a colleague

Which drugs does patent 8,474,447 protect, and when does it expire?

Patent 8,474,447 protects ATROVENT HFA and is included in one NDA.

This patent has ten patent family members in nine countries.

Summary for Patent: 8,474,447

Patent landscape, scope, and claims:

Title:	Inhaler device
Abstract:	The invention relates to a hand-held device (1), as depicted in exemplary FIG. 4, for metered dispensing of sprayable substances, particularly medicaments for inhalation, with a cartridge (3) that can be moved into the dispensing position, by pressure being applied to a housing, and with a step-by-step indexing mechanism (11) which is entrained by the cartridge (3) in the opening travel thereof and which is used to record and display the dispensing actuations that have been performed. In order to suitably design a hand-held device of the type in question with a simplified structure, in such a way that the indexing steps can be performed smoothly and safely without connection to the cartridge, it is proposed that slits (19) extend obliquely only over part of the travel of the step-by-step indexing mechanism housing (34) and that the guide pins (33) guided therein move, over the remainder of the travel of the step-by-step indexing mechanism (11), parallel to the longitudinal axis (x-x) of the step-by-step indexing mechanism.
Inventor(s):	Von Schuckmann; Alfred (Kevelaer, DE), Hochrainer; Dieter (Schmallenberg, DE), Hoelz; Hubert (Oberheimbach, DE)
Assignee:	Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:	12/677,555
Patent Claim Types: see list of patent claims	Device;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,474,447

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Boehringer Ingelheim	ATROVENT HFA	ipratropium bromide	AEROSOL, METERED;INHALATION	021527-001	Nov 27, 2004		RX	Yes	Yes	8,474,447	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,474,447

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	10 2007 045 438	Sep 22, 2007

PCT Information
PCT Filed	August 28, 2008	PCT Application Number:	PCT/EP2008/061337
PCT Publication Date:	March 26, 2009	PCT Publication Number:	WO2009/037085

International Family Members for US Patent 8,474,447

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2700201	⤷ Subscribe
Germany	102007045438	⤷ Subscribe
Denmark	2203205	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.